Adicet Bio CEO Chen Schor's 2021 pay slips 13% to $9.8M

Adicet Bio reports 2021 executive compensation

By ExecPay News

Published: April 21, 2022

Adicet Bio reported fiscal year 2021 executive compensation information on April 21, 2022.
In 2021, three Adicet Bio executives received on average a compensation package of $4.8M, a 13% increase compared to previous year.
Average pay of disclosed executives at Adicet Bio
Chen Schor, Chief Executive Officer, received $9.8M in total, which decreased by 13% compared to 2020. 71% of Schor's compensation, or $6.9M, was in option awards. Schor also received $322K in non-equity incentive plan, $536K in salary, $2M in stock awards, as well as $9.4K in other compensation.
Nick Harvey, Chief Financial Officer, received a compensation package of $2.4M. 48% of the compensation package, or $1.1M, was in option awards.
Francesco Galimi, Chief Technology Officer, earned $2.3M in 2021, a 53% increase compared to previous year.

Related executives

Chen Schor

Adicet Bio

Chief Executive Officer

Nick Harvey

Adicet Bio

Chief Financial Officer

Francesco Galimi

Adicet Bio

Chief Medical Officer

You may also like

Source: SEC filing on April 21, 2022.